Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer

Jun Ho Yi(Hanyang University Seoul Hospital), Jeeyun Lee(Sungkyunkwan University)

Scientific Reports

December 23, 2014

10.1038/srep07592

Cited by 33

Related Papers

Gastrointestinal malignancies harbor actionable MET exon 14 deletions

|Oncotarget|2015|61

<i>NTRK1</i> rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line

|Oncotarget|2015|58

Comprehensive pharmacogenomic characterization of gastric cancer

|Genome Medicine|2020|55

Acquired resistance to LY2874455 in <i>FGFR2</i>-amplified gastric cancer through an emergence of novel <i>FGFR2-ACSL5</i> fusion

|Oncotarget|2017|46

Detection of novel and potentially actionable anaplastic lymphoma kinase (<i>ALK</i>) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening

|Oncotarget|2015|37